Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Malaria Prevention
Age: Adult
Dose: Tablet – 500 mg (300 mg base)
Frequency: once weekly
Note: by mouth
Indication: Malaria Treatment
Age: Adult
Condition: Non-chloroquine-resistant
Dose: Tablet – 1 g (600 mg base)
Frequency: initial dose
Note: by mouth

Child Dose

Clinical InformationAdministration Information
Indication: Malaria Prophylaxis
Dose: by mouth (oral) – 5 mg/kg
Frequency: once weekly
Indication: Treatment
Condition: 1st dose
Dose: by mouth (oral) – 10 mg/kg
Frequency: once

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not specified – Not specified
Note: May need to reduce dose in prolonged treatment
Administration
  • Take with food
  • Complete full course
Side Effect

Drug Interaction

Drug NameRisk Factors
Phenylbutazone
Predisposes to dermatitis
Neostigmine, Pyridostigmine
Antagonizes effect

Disease Interaction

Disease NameRisk Factors
Known Or Suspected Resistant P. Falciparum Infection
Can lead to treatment failure
Porphyria
Can trigger acute attacks

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at room temperature in a dry place, away from light.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.